A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years

Clinical trial NCT06106581 · COMPLETED

Trial details

NCT number: NCT06106581
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chikungunya Virus Infection

Start date: 2023-12-18
Primary completion: 2024-07-31
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.